T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

NCT00683046 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

204

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia
Lymphoid Leukemia
Chronic Myelogenous Leukemia
Malignant Lymphoma
Hodgkin's Disease
Chronic Lymphocytic Leukemia
Myeloproliferative Disorder
Anemia, Aplastic
Myelodysplastic Syndromes

Interventions

DRUG: Fludarabine
DRUG: Melphalan
DRUG: Stem cells
DRUG: Campath

Sponsor

University of Chicago